mRNA expression of BCSG1, BTF, Bcl-2, Erα and ERβ in osteosarcoma and its significance

Academic Journal of Second Military Medical University

Volumn 30, Issue 4, 2009, Pages 416-419

  Lei, Ming ^a   Miao, Ming Yong ^b   Xu, Wei Dong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; Beast carcinoma specific gene; Estrogen receptor; Osteosarcoma; Transcription factors

Indexed keywords

BCL 2 ASSOCIATED TRANSCRIPTION FACTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCSG1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSTEOBLAST; OSTEOSARCOMA; SCHOOL CHILD; TRANSCRIPTION INITIATION; TUMOR VOLUME;

EID: 65449138697     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2009.00416     Document Type: Article

References (10)

1. Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, et al. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers[J]. Cancer Res, 2005, 65:7635-7643.
2. Xu W D, Yin H, Zhao J G, Jiao G, Wang X Y. Expression of γ-synuclein in primary osteosarcoma [J]. Acad J Sec Mil Med Univ, 2007, 28:432-435.
3. Martin T A, Gomez K, Watkins G, Douglas-Jones A, Mansel R E, Jiang W G. Expression of breast cancer specific gene-1 (BCSG-1/gamma-synuclein) is associated with tumour grade but not with clinical outcome of patients with breast cancer[J]. Oncol Rep, 2006, 16:207-212.
4. Kaseta M K, Khaldi L, Gomatos I P, Tzagarakis G P, Alevizos L, Leandros E, et al. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma[J]. J Surg Oncol, 2008, 97: 259-266.
5. Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao X, et al. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis[J]. Breast Cancer Res Treat, 2007, 101:259-267.
6. Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L, et al. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer [J]. Int J Cancer, 2007, 121:1296-1305.
7. Liu H, Lu Z G, Miki Y, Yoshida K. Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage[J]. Mol Cell Biol, 2007, 27:8180-8491.
8. Bianchini M, Martinelli G, Renzulli M, Gonzalez Cid M, Larripa I. cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib[J]. Cancer Chemother Pharmacol, 2007, 59:349-360.
9. Abdel-Fatah T M, Powe D G, Hodi Z, Reis-Filho J S, Lee A H, Ellis I O. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family [J]. Am J Surg Pathol, 2008, 32:513-523.
10. Zeng Q, Chen G G, Vlantis A C, van Hasselt C A. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway [J]. Cell Prolif, 2007, 40: 921-935.